½ÃÀ庸°í¼­
»óǰÄÚµå
1750675

µ¿¸Æ ÇÊÅÍ ½ÃÀå ±Ô¸ð, Á¡À¯À², µ¿Ç⠺м® ¸®Æ÷Æ® : ¿¬·É Ä«Å×°í¸®º°, ÃÖÁ¾ ¿ëµµº°, Áö¿ªº°, ºÎ¹® ¿¹Ãø(2025-2030³â)

Arterial Filter Market Size, Share & Trends Analysis Report By Age Category, By End-use, By Region, And Segment Forecasts, 2025 - 2030

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Grand View Research | ÆäÀÌÁö Á¤º¸: ¿µ¹® 120 Pages | ¹è¼Û¾È³» : 2-10ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

µ¿¸Æ ÇÊÅÍ ½ÃÀå ±Ô¸ð¿Í µ¿Çâ

¼¼°èÀÇ µ¿¸Æ ÇÊÅÍ ½ÃÀå ±Ô¸ð´Â 2024³â¿¡ 6¾ï 1,640¸¸ ´Þ·¯·Î ÃßÁ¤µÇ¸ç, 2025-2030³â¿¡ CAGR 6.0%·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

ÀÌ·¯ÇÑ ½ÃÀå ¼ºÀåÀÇ ¹è°æ¿¡´Â Àü ¼¼°è ½ÉÇ÷°ü Áúȯ(CVD) ¹ßº´·ü Áõ°¡, ½ÉÀå ¼ö¼ú ¼ö¿ä Áõ°¡, Àΰø½ÉÆó ±â¼úÀÇ ¹ßÀüÀÌ ÀÖ½À´Ï´Ù.

¶ÇÇÑ ½ÉÀåÁúȯ¿¡ Ãë¾àÇÑ ³ëÀÎ Áõ°¡¿Í ½ÅÈï ±¹°¡ÀÇ ÀÇ·á Á¢±Ù¼º Çâ»óÀ¸·Î ÀÎÇØ º¸´Ù ¾ÈÀüÇϰí È¿À²ÀûÀÎ ¼ö¼ú¿¡ ´ëÇÑ Çʿ伺ÀÌ ³ô¾ÆÁö¸é¼­ µ¿¸Æ ÇÊÅÍ »ê¾÷ ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ÁÖ¿ä ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ Áß Çϳª´Â CVDÀÇ ¼¼°è ºÎ´ã Áõ°¡ÀÔ´Ï´Ù. ¿¹¸¦ µé¾î 2024³â 10¿ù European Journal of Preventive Cardiology´Â CVD°¡ Àü ¼¼°è »ç¸Á°ú Áúº´ÀÇ ÁÖ¿ä ¿øÀÎÀÓÀ» °­Á¶Çß½À´Ï´Ù. ½Ä½À°ü, ¿îµ¿ ºÎÁ·, Èí¿¬, ³ëÈ­ µî ¼öÁ¤ °¡´ÉÇÑ »ýȰ ½À°üÀÌ ´ëºÎºÐÀ» Â÷ÁöÇϸç, 1990³â ÀÌÈÄ ½ÉÀ庴 ȯÀÚ ¼ö´Â ¾à µÎ ¹è·Î Áõ°¡ÇÏ¿© ÀÇ·á ºÎ´ãÀ» ³ôÀ̰í ÀÇ·áºñ¸¦ Áõ°¡½ÃÄ×À¸¸ç, 2019³â¿¡´Â 5¾ï ¸í ÀÌ»óÀÌ ½ÉÀ庴À» ¾Î°í ÀÖ½À´Ï´Ù. °°Àº ÇØ À¯·´°ú ¹Ì±¹Àº ÀÌ Áúº´¿¡ 2,800¾ï À¯·Î, 4,000¾ï ´Þ·¯ ÀÌ»óÀ» ÁöÃâÇß½À´Ï´Ù.

Àü¹®°¡µé¿¡ µû¸£¸é 2050³â±îÁö ¹Ì±¹¿¡¼­¸¸ ¸Å³â ¾à 1Á¶ 3,440¾ï ´Þ·¯°¡ ½ÉÀ庴À¸·Î ÁöÃâµÉ °¡´É¼ºÀÌ ÀÖ´Ù°í ÇÕ´Ï´Ù. ÀÌ´Â Á¶¼ÓÇÑ ¿¹¹æÃ¥ÀÇ Çʿ伺À» °­Á¶Çϰí ÀÖ½À´Ï´Ù. µ¿¸Æ ÇÊÅÍ´Â ½ÉÆó¿ìȸ¼ú Áß Ç÷Àü(±âÆ÷, Ç÷Àü, Á¶Á÷ ÆÄÆí)ÀÌ Ç÷·ù·Î À¯ÀԵǴ °ÍÀ» ¹æÁöÇÏ¿© ȯÀÚÀÇ ¾ÈÀü°ú ¼ö¼ú °á°ú¸¦ Çâ»ó½Ã۱⠶§¹®¿¡ ÀÌ·¯ÇÑ ¼ö¼ú¿¡ ÇʼöÀûÀÎ ¿ä¼ÒÀÔ´Ï´Ù. ½ÉÀåÁúȯÀÇ À¯º´·ü Áõ°¡·Î ÀÎÇØ ÀÌ·¯ÇÑ ¼ö¼úÀÌ Áõ°¡Çϰí ÀÖ´Â °ÍÀÌ ½ÃÀå È®´ë¿¡ Á÷Á¢ÀûÀ¸·Î ±â¿©Çϰí ÀÖ½À´Ï´Ù.

¼¼°è¿¡¼­ °í·É Àα¸°¡ ±ÞÁõÇϸ鼭 CVD¿¡ ´õ Ãë¾àÇϰí Á¾Á¾ ¿Ü°úÀû °³ÀÔÀÌ ÇÊ¿äÇÑ ½ÉÀåÁúȯ(CVD) ½ÃÀåÀÇ ¼ºÀåÀÌ ´õ¿í °¡¼ÓÈ­µÉ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. Our World in Data¿¡ µû¸£¸é 2024³â 11¿ù, Àü ¼¼°è 65¼¼ ÀÌ»ó Àα¸´Â ¾à 8¾ï 3,000¸¸ ¸í¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. À¯¿£ÀÇ Ãֽе¥ÀÌÅÍ¿¡ µû¸£¸é ÀÌ ¼öÄ¡´Â 2054³â¿¡´Â 17¾ï ¸íÀ¸·Î Áõ°¡ÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. µû¶ó¼­ ÇâÈÄ ¼ö½Ê³â°£ ³ëÀÎ Àα¸´Â µÎ ¹è ÀÌ»ó Áõ°¡ÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. Àü ´ë·ú¿¡¼­ °¡Àå ¸¹Àº Àα¸¸¦ º¸À¯ÇÑ ¾Æ½Ã¾Æ¿¡¼­´Â Å« º¯È­°¡ ÀϾ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

¾Æ½Ã¾Æ Áö¿ªÀÇ °í·ÉÀÚ ¼ö´Â 2050³â±îÁö 2¹è ÀÌ»ó Áõ°¡ÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ÀÌ·¯ÇÑ Àα¸Åë°èÇÐÀû º¯È­·Î ÀÎÇØ °ü»óµ¿¸Æ¿ìȸ¼ú(CABG), ÆÇ¸·Ä¡È¯¼ú, ½ÉÆó¿ìȸ¼ú Áß »öÀüÁõ »ç°í·ÎºÎÅÍ È¯ÀÚ¸¦ º¸È£Çϱâ À§ÇØ µ¿¸Æ ÇÊÅ͸¦ »ç¿ëÇÏ´Â ¼ö¼ú°ú °°Àº ½ÉÀå ¼ö¼ú¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ÀÌó·³ °í·É Àα¸ Áõ°¡´Â ¿Ü°ú¼ö¼ú¿¡¼­ µ¿¸Æ ÇÊÅÍ »ç¿ë·® Áõ°¡¿¡ Á÷Á¢ÀûÀ¸·Î ±â¿©ÇÏ¸ç µ¿¸Æ ÇÊÅÍ »ê¾÷À» È®Àå½Ã۰í ÀÖ½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå Á¶»ç ¹æ¹ý°ú ¹üÀ§

Á¦2Àå °³¿ä

Á¦3Àå µ¿¸Æ ÇÊÅÍ ½ÃÀåÀÇ º¯¼ö, µ¿Çâ, ¹üÀ§

  • ½ÃÀåÀÇ ¼­·Ð/°èÅë Àü¸Á
  • ½ÃÀå ±Ô¸ð¿Í ¼ºÀå Àü¸Á
  • ½ÃÀå ¿ªÇÐ
    • ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ ºÐ¼®
    • ½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ ºÐ¼®
  • µ¿¸Æ ÇÊÅÍ ½ÃÀå ºÐ¼® Åø
    • PorterÀÇ »ê¾÷ ºÐ¼®
    • PESTEL ºÐ¼®

Á¦4Àå µ¿¸Æ ÇÊÅÍ ½ÃÀå : ¿¬·É Ä«Å×°í¸®º°, ÃßÁ¤¡¤µ¿Ç⠺м®

  • ºÎ¹® ´ë½Ãº¸µå
  • µ¿¸Æ ÇÊÅÍ ½ÃÀå : ¿¬·É Ä«Å×°í¸® º¯µ¿ ºÐ¼®, 2024³â°ú 2030³â
  • ¼ºÀÎ
  • ½Å»ý¾Æ/¼Ò¾Æ

Á¦5Àå µ¿¸Æ ÇÊÅÍ ½ÃÀå : ÃÖÁ¾ ¿ëµµº°, ÃßÁ¤¡¤µ¿Ç⠺м®

  • ºÎ¹® ´ë½Ãº¸µå
  • µ¿¸Æ ÇÊÅÍ ½ÃÀå : ÃÖÁ¾ ¿ëµµ º¯µ¿ ºÐ¼®, 2024³â°ú 2030³â
  • º´¿ø
  • ¿Ü·¡ ¼ö¼ú ¼¾ÅÍ
  • ±âŸ

Á¦6Àå µ¿¸Æ ÇÊÅÍ ½ÃÀå : Áö¿ªº°, ÃßÁ¤¡¤µ¿Ç⠺м®

  • µ¿¸Æ ÇÊÅÍ ½ÃÀå Á¡À¯À²(Áö¿ªº°, 2024³â°ú 2030³â), 100¸¸ ´Þ·¯
  • ºÏ¹Ì
    • ¹Ì±¹
    • ij³ª´Ù
    • ¸ß½ÃÄÚ
  • À¯·´
    • ¿µ±¹
    • µ¶ÀÏ
    • ÇÁ¶û½º
    • ÀÌÅ»¸®¾Æ
    • ½ºÆäÀÎ
    • µ§¸¶Å©
    • ½º¿þµ§
    • ³ë¸£¿þÀÌ
  • ¾Æ½Ã¾ÆÅÂÆò¾ç
    • ÀϺ»
    • Áß±¹
    • Àεµ
    • È£ÁÖ
    • Çѱ¹
    • ű¹
  • ¶óƾ¾Æ¸Þ¸®Ä«
    • ºê¶óÁú
    • ¾Æ¸£ÇîÆ¼³ª
  • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
    • ³²¾ÆÇÁ¸®Ä«°øÈ­±¹
    • »ç¿ìµð¾Æ¶óºñ¾Æ
    • ¾Æ¶ø¿¡¹Ì¸®Æ®
    • Äí¿þÀÌÆ®

Á¦7Àå °æÀï ±¸µµ

  • ÁÖ¿ä ½ÃÀå Âü¿© ±â¾÷¿¡ ÀÇÇÑ ÃÖ±Ù µ¿Çâ°ú ¿µÇ⠺м®
  • ±â¾÷ ºÐ·ù
  • ±â¾÷ È÷Æ®¸Ê ºÐ¼®
  • ±â¾÷ °³¿ä
    • Medtronic
    • Pall Corporation
    • Fresenius Medical Care AG
    • Terumo Corporation
    • NIPRO
    • Haemonetics Corporation
    • ICU Medical, Inc.
    • Braile Biomedica
    • LivaNova, Inc.
    • EUROSETS
KSA

Arterial Filter Market Size & Trends:

The global arterial filter market size was estimated at USD 616.4 million in 2024 and is projected to grow at a CAGR of 6.0% from 2025 to 2030. This market growth can be attributed to the rising incidence of Cardiovascular Diseases (CVDs) worldwide, increasing demand for cardiac surgeries, and advancements in cardiopulmonary bypass technologies.

In addition, the growing geriatric population, which is more susceptible to heart conditions, and improved access to healthcare in emerging economies, fuel the need for safer and more efficient surgical interventions, boosting the demand for the arterial filter industry. One of the primary market drivers is the rising global burden of CVDs. For instance, in October 2024, the European Journal of Preventive Cardiology highlighted that CVDs are the primary cause of death and illness around the world. Modifiable lifestyle factors, such as poor diet, lack of exercise, smoking, and aging, mostly drive them. Since 1990, the number of people with heart disease has almost doubled, raising the healthcare burden and increasing medical costs. In 2019, more than 500 million people had heart disease. That year, Europe and the U.S. spent over 280 billion euros and USD 400 billion on the disease.

Experts say that by 2050, the U.S. alone might spend around USD 1,344 billion each year on heart disease. This emphasizes the need for urgent preventive policies. Arterial filters are an essential component of these surgeries, as they help prevent the introduction of an emboli (air bubbles, clots, or tissue debris) into the bloodstream during cardiopulmonary bypass, improving patient safety and surgical outcomes. The increasing number of such surgical procedures, driven by the growing incidence of heart conditions, directly contributes to market expansion.

Rapidly growing global geriatric population is expected to drive further market growth, which is more vulnerable to CVDs and often requires surgical interventions. As people age, the likelihood of developing conditions such as Coronary Artery Disease (CAD), valvular heart disease, and arrhythmias increases significantly. According to Our World in Data, in November 2024, globally, there are about 830 million people 65 years or older. According to the latest United Nations data, this number is expected to grow to 1.7 billion by 2054. Hence, the geriatric population will more than double in the next few decades. Asia, with the largest population of all continents, is expected to experience a significant shift.

The number of older people in Asia is also expected to more than double by 2050. This demographic shift has led to a higher demand for cardiac procedures like Coronary Artery Bypass Grafting (CABG), valve replacements, and surgeries where arterial filters are used to protect patients from embolic events during cardiopulmonary bypass. Thus, the growing geriatric population directly contributes to the increasing usage of arterial filters in surgical settings, expanding the arterial filter industry.

Global Arterial Filter Market Report Segmentation

This report forecasts revenue growth at regional and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the global arterial filter market report based on age category, end-use, and region:

  • Age Category Outlook (Revenue, USD Million, 2018 - 2030)
  • Adult
  • Neonatal/ Pediatric
  • End Use Outlook (Revenue, USD Million, 2018 - 2030)
  • Hospitals
  • Ambulatory Surgical Centers
  • Others
  • Regional Outlook (Revenue, USD Million, 2018 - 2030)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Denmark
    • Sweden
    • Norway
  • Asia Pacific
    • China
    • Japan
    • India
    • Australia
    • South Korea
    • Thailand
  • Latin America
    • Brazil
    • Argentina
  • Middle East and Africa (MEA)
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Market Definitions
  • 1.3. Research Methodology
    • 1.3.1. Information Procurement
    • 1.3.2. Information or Data Analysis
    • 1.3.3. Market Formulation & Data Visualization
    • 1.3.4. Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1. List of Data Sources

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. Arterial Filter Market Variables, Trends, & Scope

  • 3.1. Market Introduction/Lineage Outlook
  • 3.2. Market Size and Growth Prospects (USD Million)
  • 3.3. Market Dynamics
    • 3.3.1. Market Drivers Analysis
    • 3.3.2. Market Restraints Analysis
  • 3.4. Arterial Filter Market Analysis Tools
    • 3.4.1. Porter's Analysis
      • 3.4.1.1. Bargaining power of the suppliers
      • 3.4.1.2. Bargaining power of the buyers
      • 3.4.1.3. Threats of substitution
      • 3.4.1.4. Threats from new entrants
      • 3.4.1.5. Competitive rivalry
    • 3.4.2. PESTEL Analysis
      • 3.4.2.1. Political landscape
      • 3.4.2.2. Economic and Social Landscape
      • 3.4.2.3. Technological landscape
      • 3.4.2.4. Environmental landscape
      • 3.4.2.5. Legal landscape

Chapter 4. Arterial Filter Market: Age Category Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Arterial Filter Market: Age Category Movement Analysis, 2024 & 2030 (USD Million)
  • 4.3. Adult
    • 4.3.1. Adult Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.4. Neonatal/ Pediatric
    • 4.4.1. Neonatal/Pediatric Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Arterial Filter Market: End Use Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Arterial Filter Market: End Use Movement Analysis, 2024 & 2030 (USD Million)
  • 5.3. Hospitals
    • 5.3.1. Hospitals Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.4. Ambulatory Surgical Centers
    • 5.4.1. Ambulatory Surgical Centers Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.5. Others
    • 5.5.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Arterial Filter Market: Regional Estimates & Trend Analysis

  • 6.1. Arterial Filter Market Share, By Region, 2024 & 2030, USD Million
  • 6.2. North America
    • 6.2.1. North America Arterial Filter Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.2.2. U.S.
      • 6.2.2.1. U.S. Arterial Filter Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.2.3. Canada
      • 6.2.3.1. Canada Arterial Filter Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.2.4. Mexico
      • 6.2.4.1. Mexico Arterial Filter Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.3. Europe
    • 6.3.1. Europe Arterial Filter Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.2. UK
      • 6.3.2.1. UK Arterial Filter Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.3. Germany
      • 6.3.3.1. Germany Arterial Filter Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.4. France
      • 6.3.4.1. France Arterial Filter Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.5. Italy
      • 6.3.5.1. Italy Arterial Filter Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.6. Spain
      • 6.3.6.1. Spain Arterial Filter Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.7. Denmark
      • 6.3.7.1. Denmark Arterial Filter Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.8. Sweden
      • 6.3.8.1. Sweden Arterial Filter Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.9. Norway
      • 6.3.9.1. Norway Arterial Filter Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.4. Asia Pacific
    • 6.4.1. Asia Pacific Arterial Filter Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.2. Japan
      • 6.4.2.1. Japan Arterial Filter Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.3. China
      • 6.4.3.1. China Arterial Filter Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.4. India
      • 6.4.4.1. India Arterial Filter Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.5. Australia
      • 6.4.5.1. Australia Arterial Filter Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.6. South Korea
      • 6.4.6.1. South Korea Arterial Filter Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.7. Thailand
      • 6.4.7.1. Thailand Arterial Filter Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5. Latin America
    • 6.5.1. Latin America Arterial Filter Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.5.2. Brazil
      • 6.5.2.1. Brazil Arterial Filter Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.5.3. Argentina
      • 6.5.3.1. Argentina Arterial Filter Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.6. Middle East and Africa
    • 6.6.1. Middle East and Africa Arterial Filter Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.6.2. South Africa
      • 6.6.2.1. South Africa Arterial Filter Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.6.3. Saudi Arabia
      • 6.6.3.1. South Africa Arterial Filter Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.6.4. UAE
      • 6.6.4.1. UAE Arterial Filter Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.6.5. Kuwait
      • 6.6.5.1. Kuwait Arterial Filter Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Recent Developments & Impact Analysis by Key Market Participants
  • 7.2. Company Categorization
  • 7.3. Company Heat Map Analysis
  • 7.4. Company Profiles
    • 7.4.1. Medtronic
      • 7.4.1.1. Participant's Overview
      • 7.4.1.2. Financial Performance
      • 7.4.1.3. Product Benchmarking
      • 7.4.1.4. Recent Developments/ Strategic Initiatives
    • 7.4.2. Pall Corporation
      • 7.4.2.1. Participant's Overview
      • 7.4.2.2. Financial Performance
      • 7.4.2.3. Product Benchmarking
      • 7.4.2.4. Recent Developments/ Strategic Initiatives
    • 7.4.3. Fresenius Medical Care AG
      • 7.4.3.1. Participant's Overview
      • 7.4.3.2. Financial Performance
      • 7.4.3.3. Product Benchmarking
      • 7.4.3.4. Recent Developments/ Strategic Initiatives
    • 7.4.4. Terumo Corporation
      • 7.4.4.1. Participant's Overview
      • 7.4.4.2. Financial Performance
      • 7.4.4.3. Product Benchmarking
      • 7.4.4.4. Recent Developments/ Strategic Initiatives
    • 7.4.5. NIPRO
      • 7.4.5.1. Participant's Overview
      • 7.4.5.2. Financial Performance
      • 7.4.5.3. Product Benchmarking
      • 7.4.5.4. Recent Developments/ Strategic Initiatives
    • 7.4.6. Haemonetics Corporation
      • 7.4.6.1. Participant's Overview
      • 7.4.6.2. Financial Performance
      • 7.4.6.3. Product Benchmarking
      • 7.4.6.4. Recent Developments/ Strategic Initiatives
    • 7.4.7. ICU Medical, Inc.
      • 7.4.7.1. Participant's Overview
      • 7.4.7.2. Financial Performance
      • 7.4.7.3. Product Benchmarking
      • 7.4.7.4. Recent Developments/ Strategic Initiatives
    • 7.4.8. Braile Biomedica
      • 7.4.8.1. Participant's Overview
      • 7.4.8.2. Financial Performance
      • 7.4.8.3. Product Benchmarking
      • 7.4.8.4. Recent Developments/ Strategic Initiatives
    • 7.4.9. LivaNova, Inc.
      • 7.4.9.1. Participant's Overview
      • 7.4.9.2. Financial Performance
      • 7.4.9.3. Product Benchmarking
      • 7.4.9.4. Recent Developments/ Strategic Initiatives
    • 7.4.10. EUROSETS
      • 7.4.10.1. Participant's Overview
      • 7.4.10.2. Financial Performance
      • 7.4.10.3. Product Benchmarking
      • 7.4.10.4. Recent Developments/ Strategic Initiatives
»ùÇà ¿äû ¸ñ·Ï
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
¸ñ·Ï º¸±â
Àüü»èÁ¦